IP Library › Granted Patent US 11,439,595
Granted Patent B2
US 11,439,595 · App. 16/513,154 · Granted Sep 13, 2022

Immediate release formulations of cannabinoids

Inventors: Reinhard Nowak (Lörrach, DE); Zafar Iqbal (Sloatsburg, NY); Mohammed Taleb (Nanuet, NY)
Assignee: Glatt GmbH
A61K9/1652A61K9/0053A61K9/0056A61K9/1611A61K9/1617A61K9/1623A61K9/1635A61K9/1658A61K9/1664A61K9/1676A61K9/48A61K31/05A61K31/352A61K36/185
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,439,595
App. No.
16/513,154
Granted
Sep 13, 2022
Kind
B2
Abstract

Compositions for the immediate release of one or more cannabinoids, in which the compositions comprise a population of particles. Each particle may comprise the one or more cannabinoids and one or more intra-granule excipients. Alternatively, each particle may comprise the one or more cannabinoids and a porous bead core. The composition may be prepared by a method that involves combining the one or more cannabinoids with the one or more intra-granule excipients, and then granulating the combination, such as through fluid bed granulation, shear-induced wet granulation, or spray granulation. The composition may also be prepared by a method that involves mixing the one or more cannabinoids with a population of porous bead cores.

Claims (12)

1. A composition for immediate release of one or more cannabinoids, the composition comprising a population of particles, wherein each particle comprises:

(a) the one or more cannabinoids;

(b) one or more intra-granule excipients;

wherein about 80% of the particles is between about 20 μm and about 2000 μm in diameter; and

wherein the composition releases at least about 30% of the one or more cannabinoids over a period of about 30 minutes or less.

2. The composition of claim 1 , wherein the one or more cannabinoids comprises Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), or a combination thereof.

3. The composition of claim 1 , wherein the one or more cannabinoids comprises a combination of THC and CBD.

4. The composition of claim 1 , wherein the one or more intra-granule excipients comprises one or more diluents, one or more binders, one or more fillers, one or more surfactants/emulsifying agents, one or more disintegrants, or a combination thereof.

5. The composition of claim 1 , wherein the one or more intra-granule excipients comprises one or more cellulose derivatives.

6. The composition of claim 5 , wherein the one or more cellulose derivatives is selected from the group consisting of lactose, isomalt, cellulose, starch, cyclodextrin, mannitol, sorbitol, and a combination thereof.

7. The composition of claim 1 , wherein the composition releases about 30% of the one or more cannabinoids over a period of about 30 minutes or less.

8. The composition of claim 1 , wherein about 70% of the particles is between about 100 μm and about 700 μm in diameter.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2020
From: NOWAK, REINHARD; IQBAL, ZAFAR; TALEB, MOHAMMED
To: GLATT GMBH
Reel/Frame 052196/0230 →
Continuity (2)
Provisional Application 62700107 · Jul 18, 2018
Related Publication 20200061022A1 · Feb 27, 2020
Cited By (2)
US 12,350,371 US 12,569,505